General
Preferred name
fosaprepitant
Synonyms
L-758298 ()
FOSAPREPITANT DIMEGLUMINE ()
MK-0517 (Fosaprepitant) ()
Fosaprepitant (dimeglumine) ()
Fosaprepitant dimeglumine salt ()
MK-0517 ()
L785298 ()
Fosaprepitant (as dimeglumine) ()
Fosaprepitant meglumine ()
Emend ()
Focinvez ()
Ivemend ()
P&D ID
PD009246
CAS
265121-04-8
172673-20-0
Tags
available
drug
prodrug
Approved by
FDA
First approval
2003
2008
Drug Status
approved
investigational
Max Phase
4.0
Drug indication
Chemotherapy-induced nausea and vomiting
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Marketed formulations contain fosaprepitant dimeglumine. (GtoPdb)
MOA Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid; ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.; In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing.
Compound Sets
13
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Selleckchem Bioactive Compound Library
External IDs
106
Properties
(calculated by RDKit )
Molecular Weight
614.12
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
3
cLogP
4.37
TPSA
129.91
Fraction CSP3
0.39
Chiral centers
3.0
Largest ring
6.0
QED
0.26
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Neurokinin Receptor
TACR1
Pathway
Neuronal Signaling
GPCR/G protein
Indication
nausea, vomiting
MOA
tachykinin antagonist
Source data